Workflow
Seeking Alpha
icon
搜索文档
Capital Clean Energy Carriers: A New Name, A New Growth Engine, A Compelling Buy
Seeking Alpha· 2025-06-12 23:36
Capital Clean Energy Carriers (NASDAQ: CCEC ) is currently valued at $21.29 per share and has seen a 16% increase in its share price since the start of the year. I am of the view thatHi, I’m a passionate individual investor with a Bachelor of Commerce and a deep interest in the stock market, business strategy, and long-term wealth creation. My investing journey started out of curiosity and a desire to understand how companies grow, evolve, and survive through economic ups and downs. Over the years, that cur ...
Alphabet: Still A Textbook Buying Opportunity On Dips
Seeking Alpha· 2025-06-12 23:30
The group is designed for investors seeking to capitalize on growth stocks with robust fundamentals, buying momentum, and turnaround plays at highly attractive valuations. He identifies attractive risk/reward opportunities supported by robust price action to potentially generate alpha well above the S&P 500. He has also demonstrated outperformance with his picks. Learn more JR Research is an opportunistic investor. He was recognized by TipRanks as a Top Analyst. He was also recognized by Seeking Alpha as a ...
J.Jill Stock Discounts Some Operational Deleverage, May Become An Opportunity
Seeking Alpha· 2025-06-12 23:17
J.Jill, Inc.'s (NYSE: JILL ) Q1 '25 results were not positive, with comps worsening significantly from year-end 2024. The company guided for continued challenges in Q2. Margins were moderately protected at the merchandise level but deleverage was inevitable. Finally,Long-only investment, evaluating companies from an operational, buy-and-hold perspective.Quipus Capital does not focus on market-driven dynamics and future price action. Instead, our articles focus on operational aspects, understanding the long- ...
Norwegian Cruise Line: Investing Time Horizon Is Key
Seeking Alpha· 2025-06-12 23:16
While 2025 has been an indifferent year for equities as such, it has been particularly damaging to consumer discretionary stocks that have broadly seen a pullback year-to-date (YTD). Some stocks in the sector, however, are clearly more affected than others. A case in point is NorwegianManika is a macroeconomist with over 20 years of experience in industries including investment management, stock broking, investment banking. She also runs the profile Long Term Tips [LTT], which focuses on the generational op ...
Why I Am Maintaining My Buy Rating For Broadridge Financial
Seeking Alpha· 2025-06-12 23:08
根据提供的文档内容,未提及具体公司或行业信息,因此无法提取与公司或行业相关的关键要点。文档主要包含个人背景介绍[1]和披露声明[2][3],这些内容不符合任务要求的分析范围。建议提供包含具体行业或公司数据的新闻素材以便进行专业分析。
EyePoint Stock: Retaining My 'Risky Buy' Call - Pivotal Data Due Early 2026
Seeking Alpha· 2025-06-12 23:03
If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?The group is for both novice and experienced biotech investors. It provides catalysts to look out for and buy and sell ratings. It also provides product sales and forecasts for all the Big Pharmas, forecasting, int ...
Victoria's Secret: I Don't See Any Upside Potential In The Near Term
Seeking Alpha· 2025-06-12 22:51
I give a hold rating for Victoria’s Secret & Co. (NYSE: VSCO ) as I think the stock sits at a difficult crossroad. While there are early signs that the turnaround is gaining traction, the core intimates businessI’m a fundamental, valuation-driven investor with a strong focus on identifying businesses that have the potential to scale over time and unlock massive terminal value. My investment approach centers around understanding the core economics of a business—its competitive moat, unit economics, reinvestm ...
Vericel Corporation: Moving From Sell To Neutral
Seeking Alpha· 2025-06-12 22:23
Bret leads the investing group The Biotech Forum , in which he and his team offer a model portfolio with their favorite 12-20 high upside biotech stocks, live chat to discuss trade ideas, and weekly research and option trades. The group also provides market commentary and a portfolio update every weekend. Learn More . Live Chat on The Biotech Forum has been dominated by discussion of covered call opportunities in recent quarters. To see what I and the other season biotech investors are targeting as trading ...
Archer Aviation: A High-Risk/Reward Play Driven By A Massive eVTOL Market Opportunity
Seeking Alpha· 2025-06-12 22:22
Analyst's Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. After reading a lot of articles on Archer Aviation Inc. ( ACHR ) some full of optimism and others over ...
Amicus Therapeutics: Opportunity Awaits In This Beaten Down Pharma
Seeking Alpha· 2025-06-12 22:14
Writing under the pseudonym "out of ignorance", I very much regard investing as a learning process. Investing failures are tuition paid. Investing successes enter the trove of lessons learned. In my Seeking Alpha articles I share my experience from decades of investing and from ~5 years of focused research on a variety of stocks, in recent years with a primary emphasis on healthcare stocks. I greatly appreciate those who take the time to share their reactions to articles, particularly those who share releva ...